1Department of Pharmaceutics, PRES'S College of Pharmacy, Chincholi, Nashik-422101, Maharashtra, India
2Research and Development Cell, Glenmark Pharmaceuticals Ltd., Sinnar, Nashik, Maharashtra, India
*Corresponding Author E-mail: anaghabaviskar12@gmail.com
Online published on 3 April, 2013.
Solid lipid nanoparticles (SLN) have attracted increasing attention during recent years. SLN consist of biodegradable physiological lipids or lipidic substances and stabilizers which are generally recognized as safe (GRAS) or have a regulatory accepted status. In engineering of SLN lipid and surfactant are very important as they influence the particle size and entrapment efficiency. This paper presents an overview about the effect of lipid and surfactant on formulation of SLN. Lipid crystallinity and polymorphism, the two criteria are studied for stability of SLN. Special attention is paid to the relation between drug loading profile and the release in lipid nanoparticle.
Solid lipid nanoparticles, crystallinity, polymorphism, stability, drug loading profile, release from SLN